Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists
- DOI
- 10.1016/j.aohep.2023.101142
- Published
- 2023-11
- Container
- Annals of Hepatology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.aohep.2023.101142,
title = {Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists},
author = {Lucy Gracen and Withma Muthukumara and Melanie Aikebuse and Anthony Russell and James O'Beirne and Katharine M. Irvine and Suzanne Williams and Gaurav Puri and Patricia C. Valery and Kelly L. Hayward and Elizabeth E. Powell},
year = {2023},
journal = {Annals of Hepatology},
doi = {10.1016/j.aohep.2023.101142},
url = {https://doi.org/10.1016/j.aohep.2023.101142}
}RIS
TY - JOUR TI - Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists AU - Lucy Gracen AU - Withma Muthukumara AU - Melanie Aikebuse AU - Anthony Russell AU - James O'Beirne AU - Katharine M. Irvine AU - Suzanne Williams AU - Gaurav Puri AU - Patricia C. Valery AU - Kelly L. Hayward AU - Elizabeth E. Powell PY - 2023 JO - Annals of Hepatology DO - 10.1016/j.aohep.2023.101142 UR - https://doi.org/10.1016/j.aohep.2023.101142 ER -
APA
Gracen, L., Muthukumara, W., Aikebuse, M., Russell, A., O'Beirne, J., Irvine, K. M., Williams, S., Puri, G., Valery, P. C., Hayward, K. L., & Powell, E. E. (2023). Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of Hepatology. https://doi.org/10.1016/j.aohep.2023.101142
Source records
- crossref · retrieved 2026-09-26T21:51:12.870Z